Due to the lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.Updates regarding government operating status and resumption of normal operations can be found at http://www.usa.gov.
Notice Number: NOT-OD-10-080
Update: The following update relating to this announcement has been issued:
Release Date: April 15, 2010
National Institutes of Health (NIH), (http://www.nih.gov)
This notice clarifies the existing resubmission policy as announced in NOT-OD-09-016 and NOT-OD-09-003, which collectively stated that applications submitted for due dates before January 25, 2009 are allowed two resubmissions (A1 and A2), and applications submitted for due dates on or after January 25, 2009 are allowed only one resubmission (A1). The resubmission policy applies to all types of applications, every activity code, and applications submitted in response to Program Announcements (PA, PAR, PAS) or Requests for Applications (RFA).
Clarification of Resubmission Policy
January 25, 2009 was chosen as the cut-off date because it is the first standing due date for applications to be considered for Fiscal Year 2010 funding (Cycle I/October 2009 Council). In the Enhancing Peer Review process, NIH has generally coordinated significant changes with the start of a new fiscal year. However, the situation for some applications submitted under the continuous submission option, requires further clarification to permit investigators to accurately determine their resubmission options.
This notice clarifies that the determination of whether an application is allowed one or two resubmissions ultimately depends upon the fiscal year of funding and the assigned council date. Applicants can determine the assigned council date for each application by examining the first page of the Summary Statement, or by viewing the Status page in eRA Commons.
Determination of eligibility to submit A2 resubmissions
Determination of last opportunity to submit A2 resubmissions
NIH action when an invalid A2 application is received
If an applicant submits an A2 application for which only one resubmission is allowed, the A2 application will be administratively withdrawn by the Center for Scientific Review (CSR) Division of Receipt and Referral and the Program Director/Principal Investigator and applicant institution will be notified.
Determination of New Application Status
A new application is expected to be substantially different in content and scope with more significant differences than are normally encountered in a resubmitted application. A new application should include substantial changes in all sections of the Research Plan, particularly in the Specific Aims and the Research Strategy sections. There should be fundamental changes in the questions being asked and/or the outcomes examined. Changes to the Research Plan should produce a significant change in direction and approach for the research project. In the case of institutional Training and institutional Career Development applications, there must be a significant or substantial change in the programmatic, leadership, administrative, or other critical aspect of the program. Rewording of the Title and Specific Aims or incorporating minor changes in response to comments of reviewers in the most recent Summary Statement does not constitute substantial changes in scope, direction or content. Requests for review by a different review committee or funding consideration by a different NIH Institute are not sufficient reasons to consider an application as new. Submission to a different FOA is also not sufficient to make an application new (there are exceptions for applications following an RFA or changing activity code; see NOT-OD-09-100).
Applications received by the NIH are screened multiple times and checked to determine if the application is a new application, not simply another version of a project that has already received the maximum number of reviews. The first check is done within the CSR Division of Receipt and Referral. Subsequent checks are performed by the Scientific Review Officer (SRO) in charge of the review meeting and by NIH program staff.
Within CSR staff may refer it to a CSR-convened committee that provides further analysis and recommendations to the Division of Receipt and Referral. The evaluation process includes the analysis of previous applications and summary statements to determine the similarities to and differences from the current application. Other Institutes and Centers have their own evaluation processes. When applications are determined to be in violation of the resubmission policy, they are administratively withdrawn and are not reviewed. The CSR Division of Receipt and Referral informs the Program Director/Principal Investigator and institution of this determination.
For additional information or questions, please contact:
Division of Receipt and Referral
Center for Scientific Review
6701 Rockledge Drive MSC 7720
Bethesda, MD 20892-7720
Voice: (301) 435-0715
Fax: (301) 480-1987
Or send an email to EnhancingPeerReview@mail.nih.gov. For more information on NIH’s Enhancing Peer Review effort, visit http://enhancing-peer-review.nih.gov/.